Abstract
Autoantibodies against complement proteins are involved in the pathological process of many diseases, including lupus nephritis, C3 glomerulopathies, and atypical hemolytic uremic syndrome. This method describes the detection of autoantibodies targeting the central complement component C3 by ELISA. These autoantibodies (IgG) are detected in up to 30% of the patients with lupus nephritis and more rarely in cases with C3 glomerulopathies. These autoantibodies recognize the active fragment C3b and have overt functional consequences. They enhance the formation of the C3 convertase and prevent the inactivation of C3b by Factor H and complement receptor 1. Moreover, they enhance the deposition of complement activation fragments on activator surfaces, such as apoptotic cells. The data currently available on the relations of anti-C3 autoantibodies with clinical, laboratory, and histological markers for activity of lupus nephritis, as well as the relations of anti-C3 with classical immunological markers for activity of autoimmune process in patients with lupus nephritis, such as hypocomplementemia and high levels of anti-dsDNA, could identify these autoantibodies as a potential marker for evaluation the activity of lupus nephritis. These autoantibodies correlate with the disease severity and can be used to identify patients with lupus nephritis who were prone to flare. Therefore, the detection of such autoantibodies could guide the clinicians to evaluate and predict the severity and to manage the therapy of lupus nephritis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lachmann PJ (1967) Conglutinin and immunoconglutinins. Adv Immunol 6:479–527
Janssen BJ, Huizinga EG, Raaijmakers HC et al (2005) Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437:505–511
Janssen BJ, Christodoulidou A, McCarthy A et al (2006) Structure of C3b reveals conformational changes that underlie complement activity. Nature 444:213–216
Nilsson B, Ekdahl KN, Svarvare M et al (1990) Purification and characterization of IgG immunoconglutinins from patients with systemic lupus erythematosus: implications for a regulatory function. Clin Exp Immunol 82:262–267
Nilsson B, Ekdahl KN, Sjoholm A et al (1992) Detection and characterization of immunoconglutinins in patients with systemic lupus erythematosus (SLE): serial analysis in relation to disease course. Clin Exp Immunol 90:251–255
Kenyon KD, Cole C, Crawford F et al (2011) IgG autoantibodies against deposited C3 inhibit macrophage-mediated apoptotic cell engulfment in systemic autoimmunity. J Immunol 187:2101–2111
Vasilev VV, Noe R, Dragon-Durey MA et al (2015) Functional characterization of autoantibodies against complement component C3 in patients with lupus nephritis. J Biol Chem 290:25343–25355
Birmingham DJ, Bitter JE, Ndukwe EG et al (2016) Relationship of circulating anti-C3b and anti-C1q IgG to lupus nephritis and its flare. Clin J Am Soc Nephrol 11:47–53
Marinozzi MC, Roumenina LT, Chauvet S et al (2017) Anti-factor B and anti-C3b autoantibodies in C3 glomerulopathy and Ig-associated membranoproliferative GN. J Am Soc Nephrol 28:1603–1613
Vasilev VV, Radanova M, Lazarov VJ et al (2019) Autoantibodies against C3b-functional consequences and disease relevance. Front Immunol 10:64
Potter BJ, Brown DJ, Watson A et al (1980) Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn’s disease. Gut 21:1030–1034
Ngu JL, Soothill JF (1969) Immunoconglutinin and complement changes in children with acute nephritis. Clin Exp Immunol 5:557–566
Ngu JL, Barratt TM, Soothill JF (1970) Immunoconglutinin and complement changes in steroid sensitive relapsing nephrotic syndrome of children. Clin Exp Immunol 6:109–116
Ngu JL, Blackett K (1970) Complement and immunoconglutinin changes in the nephrotic syndrome of adult Africans. J Trop Med Hyg 73:250–254
Chen Q, Muller D, Rudolph B et al (2011) Combined C3b and factor B autoantibodies and MPGN type II. N Engl J Med 365:2340–2342
Durand CG, Burge JJ (1984) A new enzyme-linked immunosorbent assay (ELISA) for measuring immunoconglutinins directed against the third component of human complement. Findings in systemic lupus erythematosus. J Immunol Methods 73:57–66
Noe R, Chauvet S, Togarsimalemath SK et al (2019) Detection of autoantibodies to complement components by surface Plasmon resonance-based technology. Methods Mol Biol 1901:271–280
Chauvet S, Roumenina LT, Aucouturier P et al (2018) Both monoclonal and polyclonal immunoglobulin contingents mediate complement activation in monoclonal gammopathy associated-C3 glomerulopathy. Front Immunol 9:2260
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Radanova, M., Roumenina, L.T., Vasilev, V. (2021). Detection of Anti-C3b Autoantibodies by ELISA. In: Roumenina, L.T. (eds) The Complement System. Methods in Molecular Biology, vol 2227. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1016-9_13
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1016-9_13
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1015-2
Online ISBN: 978-1-0716-1016-9
eBook Packages: Springer Protocols